The expression of co-stimulatory molecules and their relation- ship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia-Reference-Cited by-同舟云学术

The expression of co-stimulatory molecules and their relation- ship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia

Published:1998-09 Issue:5 Volume:102 Page:1257-1262
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Maeda Akinori,Yamamoto Kokichi,Yamashita Kouhei,Asagoe Kohsuke,Nohgawa Masaharu,Kita Kenkichi,Iwasaki Hiromichi,Ueda Takanori,Takahashi Atsushi,Sasada Masataka

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.00901.x/fullpdf

Reference28 articles.

1. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance;Archimbaud;Leukemia Research,1992

2. Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells;Archimbaud;Leukemia,1991

3. B70 antigen is a second ligand for CTLA-4 and CD28;Azuma;Nature,1993

4. Co-stimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4;Chen;Cell,1992

5. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity;Chen;Journal of Experimental Medicine,1994

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric-based detection of CD80 is a useful diagnostic marker of acute myeloid leukemia in dogs;Frontiers in Veterinary Science;2024-08-19

2. Co-stimulatory pathway competitive assay development using Liquid chromatography–tandem mass spectrometry (LC-MS/MS);Journal of Pharmaceutical and Biomedical Analysis;2024-05

3. The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma;Experimental Hematology;2023-05

4. CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells;Cancer Immunology, Immunotherapy;2023-04-11

5. Fusion of Invasive Tumor Cells with Infiltrating Macrophages Fuels Epithelial-Mesenchymal Transition and Adaptive Immune Evasion;2022-11-23